Northern Mariana Islands Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Northern Mariana Islands Health News.

Press releases published on June 3, 2026

Jun. 3, 2026

Hopstem hNPC01 Cell Injection Earns FDA RMAT Designation for Chronic Stroke Therapy

Indeterminate GlobeNewswire

Jun. 3, 2026

Levicept to Present Data Suggesting LEVI-04 May Modify Disease in Osteoarthritis at EULAR 2026

Indeterminate GlobeNewswire

Jun. 3, 2026

Omnix Medical Announces First Patients Dosed in Phase II Trial of Antimicrobial Lead Compound OMN6

Indeterminate GlobeNewswire

Jun. 3, 2026

iHerb's 618 Big Benefits: Rewarding Users in Hong Kong and Southeast Asia

Indeterminate GlobeNewswire

Jun. 3, 2026

iHerb618重磅福利回饋香港及東南亞用戶

Indeterminate GlobeNewswire

Jun. 3, 2026

Chiesi Global Rare Diseases to Launch the Second Edition of Find For Rare at 2026 ERA Congress to Advance Research in Lysosomal Storage Disorders

Indeterminate GlobeNewswire

Jun. 3, 2026

Nicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 24, 2026 and appointment of an ad hoc representative

Indeterminate GlobeNewswire

Jun. 3, 2026

Nicox : Convocation à l’Assemblée Générale Ordinaire et Extraordinaire le 24 juin 2026 et désignation d’un mandataire ad hoc

Indeterminate GlobeNewswire

Jun. 3, 2026

JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)

Indeterminate GlobeNewswire

Jun. 3, 2026

argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren’s Disease at EULAR 2026

Indeterminate GlobeNewswire

Jun. 3, 2026

Inteleos and Medvarsity Partner to Expand Global POCUS Education Access

Indeterminate GlobeNewswire

Jun. 3, 2026

شراكة Inteleos و Medvarsity لتوسيع التوافر العالمي لتعليم التصوير بأجهزة الموجات فوق الصوتية المتنقلة لدى المريض (POCUS)

Indeterminate GlobeNewswire

Jun. 3, 2026

ASCO 2026 | Updated Data from an Oral Presentation of InnoCare's Novel BCL2 Inhibitor Mesutoclax in MDS and AML Released

Indeterminate GlobeNewswire